Published in Women's Health Weekly, March 16th, 2006
"HIV-1-exposed infants were randomized to receive 1 of 2 formulations of vCP205 or placebo at birth and 4, 8, and 12 weeks," scientists in the United States report.
According to D.C. Johnson and colleagues at Sinai Children's Hospital and Rosalind Franklin University of Medicine and Science in North Chicago, "The vaccines were safe. Lymphoproliferative...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly